FMT In High-Risk Acute GVHD After ALLO HCT

Clinical trial NCT04139577 · COMPLETED

Trial details

NCT number: NCT04139577
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Graft-Versus-Host Disease (Gvhd) Grade Hematopoietic Cell Transplantation Fecal Microbiota Transplant

Start date: 2021-06-18
Primary completion: 2022-08-03
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.